We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Consolidation Provides Free Access to DNA Sequence Information

By LabMedica International staff writers
Posted on 11 Jun 2010
Three major sequence resources have consolidated to become Europe's primary access point to globally concise DNA and RNA sequence data. More...


The European Nucleotide Archive (ENA) is freely available from the European Bioinformatics Institute (EMBL-EBI; Cambridge, UK), a part of European Molecular Biology Laboratory.

Faster and low cost DNA sequencing has led to previously unheard of amounts of data being deposited in the public nucleotide sequence databases: today, ENA holds over 20 terabases of nucleotide sequence which, combined with associated information (annotation), occupies 230 terabytes of disk space. Thoroughly annotated and crosslinked sequence records from the EMBL Nucleotide Sequence Database (EMBL-Bank) form the backbone of the ENA. But significantly, ENA now also provides direct access to raw sequence data: the European Trace Archive contains raw data from electrophoresis-based sequencing machines and was previously maintained at the Wellcome Trust Sanger Institute (Cambridge, UK); the Sequence Read Archive (SRA) is a newly established repository for raw data from next-generation (array-based) sequencing platforms. Improved submission and data-access tools make it easier for ENA's users to share their sequence data.

"Large-scale DNA sequencing was previously the domain of a small number of specialist labs, but next-generation sequencing has made it accessible to the majority of molecular life scientists,” explained Graham Cameron, the EMBL-EBI's associate director. "The launch of ENA reflects our continuing commitment to promoting scientific progress by providing global access to nucleotide sequence information. This has been central to EMBL's mission since the 1980s when we launched the EMBL Data Library.”

Guy Cochrane, who leads the ENA team, stated that "ENA has been designed to provide our users with improved access both to annotated and to raw sequence data through the same user-friendly interface. It provides graphical browsing, web services, text search, and a new rapid sequence similarity search. ENA also provides access to related information, with over 190 million cross references to external records, many of which are in other EMBL-EBI data resources.”

The ENA team plans to launch many new features for the resource over the next twelve months, including enhancements to the user-friendly browser, improved interactive submissions tools, and organism- and project-centered portals into ENA data.

Tim Hubbard, head of informatics at the Wellcome Trust Sanger Institute, said, "As major generators of DNA sequence data, it is important to us that the research community has ready access not only to annotated sequence information, but also to raw data. It's great to see the launch of ENA with new interfaces for users to this vast and rapidly growing body of information.”

Related Links:

European Bioinformatics Institute


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.